The FDA...Panel is Mostly Doctors so if they like it, chances are MANY more clinicians will love it too. AND to boot this market is HUGE !! Who wouldn't love something that will add diagnostic accuracy to detecting vascular lesions ? My best bet is that this software will help, ABOVE ALL save MANY MANY lives in the world. THIS type of adjuntive diagnostic tool is what most envisioned would be the future,ie 3D imaging of EVERYTHING to see things at an acute level to add to the certainty of diagnosis.In any event MKI now has a VERY BRIGHT future ahead of it. Just a matter of marketing the product to the WORLD and the USA is a good start !!
PS BCG honestly I don't know how high this will go and truly NO ONE does. But what I can tell you is that MKI should never have been 5 cents AND that it shoud not be 28 cents either. Based on the size of this ever growing market, sky is the limit. GLTA and I will be looking to add to my current position tomorrow.